Arrow
UV RayBlur boxBlur BoxBlur boxBlur Box
Icon
August 6, 2026

5 Common Mistakes to Avoid While Determining State Licensing Requirements

Ryan Hall
Director, Marketing

Determining which state licenses your facility needs sounds straightforward. In practice, it is one of the most error-prone processes in pharmaceutical supply chain compliance, and errors can result in fines, lost trading partner relationships, and, in some cases, the inability to distribute product in a state.

Under-Licensing vs.Over-Licensing: The Two Costly Outcomes

Incomplete or incorrect determination of which state licenses and federal registrations to obtain can result in two costly outcomes:

  1. Under-licensing means failing to obtain a required license, exposing your organization to civil penalties, shipment holds, trading partner disputes, and potential interruption of operations.
  2. Over-licensing means obtaining licenses you do not need, adding unnecessary fees, bond requirements, inspection obligations, and administrative burden with no operational benefit.

Both outcomes are avoidable. But avoiding them requires understanding where the process most commonly breaks down.

The 5 Common Mistakes That Lead to Licensing Errors

Let’s review the five most common mistakes that state licensing professionals make when trying to determine their state licensing requirements.

Mistake 1: Overlooking Licensing Agencies

There are over 200 agencies across all 56 US jurisdictions with the authority to regulate pharmaceutical supply chain entities.

It is not just Boards of Pharmacy. Departments of Health, Departments of Agriculture, and Bureaus of Narcotics all play a role depending on the state and the business activity.

The agency that licenses a wholesale distributor in one state may be an entirely different agency in another.

For example: in California, wholesale distributors are licensed through the Board of Pharmacy. In Louisiana, it is the Board of Drug and Device Distributors. In North Carolina, it falls under the Department of Agriculture. Missing an agency means missing a license, which results in non-compliance.

Mistake 2: Incorrectly Determining Your Business Model

Each state agency defines business models in its own way, and those definitions do not always align with how your organization describes itself.

A 503B outsourcing facility, for example, may be classified as a manufacturer in one state and required to apply under a pharmacy application in another.

This problem is compounded by several factors:

  • Agencies sometimes have unclear or no definitions at all
  • Relevant definitions are often scattered across statutes, rules, FAQs, and application forms
  • Agencies use terminology that does not map neatly to standard industry categories

Getting this wrong means obtaining the wrong license and missing the right one.

Mistake 3: Overlooking License Applications

Even when you have identified the correct agency and business model, finding the right application is not always obvious.

Application titles and descriptions do not always reflect the business models they cover.

In Georgia, a single pharmacy facility application covers 13 different entity types with no clear indication of which applies to your facility.

Controlled substance registrations add another layer of complexity. Some applications include them, and others require a separate application through a different agency entirely.

Renewal forms can be equally confusing, and the submission process itself varies. Some states require hard copy forms, others require online portal submissions that require account creation just to access the application details.

Mistake 4: Incorrectly Deciding Whether to Obtain a License

Once you have located the right application, you still have to determine whether your facility is actually required to hold that license. This is where judgment calls become unavoidable, and where inconsistency can create real exposure.

Sometimes, information that is posted may not specifically address the business activities that your business conducts, which may make it difficult to decide whether you must obtain the license.

Agency staff points you to regulations and FAQs, but they cannot provide legal advice on how those rules apply to your specific business model. One representative may tell you a license is not required, and another may determine that it is. Unfortunately, the responsibility for the final determination rests with your organization, not the agency.

Mistake 5: Failing to Document Licensing Decisions

Decisions not to pursue a license are just as important to document as decisions to obtain one.

If your organization is audited and a regulator asks why a license was not obtained in a particular state, you need to be able to produce documentation that supports your reasoning, whether that is a citation to the relevant regulation, a summary of your agency communication, or both.

Any time you contact an agency to clarify a requirement and receive guidance that a license is not needed, document who you spoke with, the date, and what was discussed, and follow up with a written summary. Even when a license is not required, other state-specific obligations such as reporting requirements may still apply.

Your organization should operate as if it could be inspected on any day, at any time. A well-documented licensing file is one of the most practical ways to demonstrate that your compliance program is built on defensible reasoning, not assumptions.

The Stakes of Non-Compliance

A cease-and-desist order or license revocation your organization can no longer operate in that state. If that state represents a meaningful revenue stream, the impact to your business can be significant, and these matters are not resolved quickly. Reinstating a revoked license or responding to a cease-and-desist can take months.

Trading partners are also paying closer attention. More organizations across the life sciences supply chain are actively verifying license status in real time using state board databases. If a trading partner discovers a missing or lapsed license, they will not wait for you to fix it. In many cases, shipments are suspended immediately, and restoring that relationship is harder than maintaining compliance in the first place.

Disciplinary actions carry a compounding effect as well. Any discipline received in one state must be reported to every other state where you hold a license, often within 30 days. Failing to report it on time can trigger new discipline in those states, restarting the cycle. This domino effect can turn a single compliance gap into a multi-state crisis.

Each of these five mistakes can occur at any point in the licensing determination process, and each one creates exposure that is difficult and costly to correct after the fact.

A structured, documented approach to licensing determinations, one that accounts for the right agencies, the correct business model definitions, and the specific requirements of each jurisdiction, is the foundation of a defensible compliance program.

Need Assistance Determining Your Licensing?

LighthouseAI's Rapid Assessments identify all state licensing requirements across all 56 US jurisdictions, combining software precision with the expertise of our state licensing professionals to ensure your licensing portfolio is complete and defensible.

See how LighthouseAI Rapid Assessments work. Request a Demo

About the Author

Ryan Hall is Director of Marketing at LighthouseAI, with 10+ years of experience across the pharmaceutical industry. He leads the development of educational content, including webinars, white papers, and newsletters aimed at keeping LighthouseAI's clients informed and ahead of the curve.

Read latest articles